Sort
48,018 grants matching “immunotherapy”
Costimulation blockade, chimerism and tolerance across varying degrees of MHC dis
$744,915Christian P Larsen · Emory University · U19 · FY2008 · AI
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$744,264Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
THERAPEUTIC COCAINE VACCINE
$744,249Yale University · U19 · FY2000 · DA
Immune reconstitution following autologous and allogeneic stem cell transplant
$744,123Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Development of highly neutralizing nanobodies against HIV-1 and SARS-CoV-2
$743,993Rafael C Casellas · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR
Longitudinal Immunological Impact of SARS-CoV-2 Infection
$743,919Timothy Jensen Henrich · University Of California, San Francisco · R01 · FY2020 · AI
Protective versus deleterious immune responses that impact vaccine efficacy against Staphylococcus aureus bloodstream infection
$743,809Hatice Karauzum · Integrated Biotherapeutics, Inc. · R01 · FY2020 · AI
Allergen Loaded Nanoparticles for Food Allergy Tolerance
$743,761Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2023 · AI
Epigenetic programing of CD4+ T cell proliferation, survival and function during chronic viral infection
$743,752Jeffrey Scott Hale · Utah State Higher Education System--University Of Utah · R01 · FY2025 · AI
Targeting HIV-specific CAR T cells to the gut for the durable remission of HIV
$743,696Pamela J Skinner · University Of Minnesota · R01 · FY2023 · DK
Winship National Clinical Trials Network Lead Academic Participating Site
$743,680Kristin Higgins · Emory University · UG1 · FY2021 · CA
Defining & Characterizing Novel Mechanisms by which HIV-infected Primary CD4+ T-cells Intrinsically Resist Elimination by CTL
$743,679R. Brad Jones · Weill Medical Coll Of Cornell Univ · R56 · FY2020 · AI
Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics
$743,067Hua Wu · Sab Capra, Llc · R42 · FY2020 · AI
Immune and transcriptomic biomarkers of progressive oral premalignant lesions
$743,064Fatemeh Momen Heravi · Columbia University Health Sciences · U01 · FY2023 · DE
Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
$742,927Mandana Khalili · University Of California, San Francisco · U01 · FY2019 · DK
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2025 · CA
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$742,887Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2024 · CA
Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies
$742,884Rebecca Marie Lynch · George Washington University · R01 · FY2022 · AI
Ikaros regulation: study on hemo-lymphopoiesis
$742,864Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2025 · HL
Identification and eliminationof HIV reservoirs in oral lymphoid tissues by engineered NK cells.
$742,726Jonathan Karn · Case Western Reserve University · R01 · FY2019 · DE
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G
$742,658James D. Marks · University Of California, San Francisco · U01 · FY2008 · AI
01 Inflammation, Immunology and Immunotherapeutics Program
$742,500Donald J Buchsbaum · University Of Alabama At Birmingham · P30 · FY2020 · CA
The role of the innate immune system on Treg reprogramming in human autoimmune di
$742,405David A. Hafler · Yale University · U01 · FY2015 · AI
Modelling the dynamics of spontaneous clonal hematopoiesis in pet dogs during cancer therapy
$742,391Cheryl A London · Tufts University Boston · R01 · FY2025 · CA
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$742,329Suresh S Ramalingam · Emory University · UG1 · FY2021 · CA